Perlmutter Cancer Center at NYU Langone was 1 of 3 sites to take part in the Association of Cancer Care Centers quality improvement initiative in myeloproliferative neoplasms (MPNs).

On behalf of the Canadian MPN Research Foundation, CURE spoke with Dr. Pierre Villeneuve, from the University of Ottawa, about MPN resources and support groups available to patients and loved ones.

The individual behavior of a patient’s myeloproliferative neoplasm (MPN) will determine how the disease is monitored and managed in the long term, explained Jennifer Vaughn, MD, of The Ohio State ...

Patients with myeloproliferative neoplasms should keep their care team up to date on any symptoms they’re experiencing, an expert said. Myeloproliferative neoplasm (MPN) symptoms can often appear as ...

Myeloproliferative neoplasms (MPNs) represent a cluster of conditions characterized by the excessive production of blood cells within the bone marrow. Among MPN patients, abnormal quantities of red ...

Patients with myeloproliferative neoplasms (MPN) who later develop ph+ chronic myelogenous leukemia (CML): A case series. This is an ASCO Meeting Abstract from the 2017 ASCO Annual Meeting I. This ...

People who use metformin are less likely to develop a myeloproliferative neoplasm (MPN) over time, indicating that the treatment may help prevent the development of certain types of cancers, according ...

Clinical trials offer a unique treatment experience when you live with myeloproliferative disorders. Lower cost of care, direct access to a specialized MDS medical team, and the opportunity to try new ...

—In a new study, revascularization reduced major adverse cardiovascular and limb events (MACLE) and amputations, but it increased bleeding and stroke risk, highlighting the need for careful risk ...

Annual awards program recognizes extraordinary patients, health care professionals and caregivers for their outstanding efforts in bringing understanding, compassion, and strength to the ...